Sequent Scientific is India’s leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.
Financial Results:
Sequent Scientific Ltd reported Revenues for Q1FY24 of ₹333.21 Crores down from ₹341.32 Crore year on year, a fall of 2.38%.
Total Expenses for Q1FY24 of ₹366.17 Crores up from ₹359.93 Crores year on year, a rise of 1.73%.
Consolidated Net Profit of -₹34.68 Crores from -₹15.32 Crores in the same quarter of the previous year.
The Earnings per Share is -₹1.40, from -₹0.60 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.